Judith Butler on the Violence of Neglect Amid a Health Crisis
By Francis Wade,
The Nation
| 05. 13. 2020
A conversation with the theorist about her new book, The Force of Nonviolence, and the need for global solidarity in the pandemic world
Image via Wikimedia Commons
Judith Butler has achieved a status that few other living academics have acquired: For each published work that she issues, reams of discussion and critique are produced in response, so much so that they have engendered microdisciplines in the many fields in which she is an expert: gender, politics, literary studies, and more. Her argument for gender as performative, which first gained attention through her 1990 book Gender Trouble, established her as a leading gender theorist before subsequent works directed greater focus toward the exercise of state power via, among others, rhetoric and violence.
In the wake of the 9/11 attacks, Butler began working on a series of essays, later collected into Precarious Life: The Powers of Mourning and Violence(2004), in which she elaborated her thesis on “grievability.” She argued that the loss of certain communities—generally First World, white, middle class, heterosexual—produces a national mourning that is recognized and amplified—in obituary pages, news channels, and public commemoration services. Others seen as weak or different (such as people with AIDS in the US and the...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...